Of Monsters and Men
By George Estreich, Biopolitical Times guest contributor
| 11. 29. 2012
To be interested in questions of human enhancement, while also being a sucker for Hollywood blockbusters about superheroes, makes for an odd movie experience. Immersed in a fictional world both saved and threatened by the enhanced, you’re aware of the world you’ve just paid to escape. You feel doubled, like the superheroes themselves—though since you’re sitting on the couch and not saving the world, the division is less profound. You don’t have secret powers, just cognitive dissonance; your perception, not your identity, is split.
A few nights ago, I watched The Amazing Spider-Man on Blu-Ray. (Warning: many spoilers ensue.) The movie reboots the franchise that began in 2002, and this time around, the genetic enhancement of human beings is far more central to the plot. Just as in the first series, the high school student Peter Parker, bitten by a genetically modified spider, develops superpowers; but this time around, the spider comes from a corporation whose business model depends on “cross-species genetics,” and Peter’s nemesis—the scientist Curtis Connors, once the research partner of Peter’s deceased father—is a man with one...
Related Articles
By Jenny Lange, BioNews | 12.01.2025
A UK toddler with a rare genetic condition was the first person to receive a new gene therapy that appears to halt disease progression.
Oliver, now three years old, has Hunter syndrome, an inherited genetic disorder that leads to physical...
By Rachel Hall, The Guardian | 11.20.2025
Couples are needlessly going through IVF because male infertility is under-researched, with the NHS too often failing to diagnose treatable causes, leading experts have said.
Poor understanding among GPs and a lack of specialists and NHS testing means male infertility...
By Pam Belluck and Carl Zimmer, The New York Times | 11.19.2025
Gene-editing therapies offer great hope for treating rare diseases, but they face big hurdles: the tremendous time and resources involved in devising a treatment that might only apply to a small number of patients.
A study published on Wednesday...
By Aisha Down, The Guardian | 11.10.2025
It has been an excellent year for neurotech, if you ignore the people funding it. In August, a tiny brain implant successfully decoded the inner speech of paralysis patients. In October, an eye implant restored sight to patients who had...